Related Experiment Video
Updated: Apr 30, 2026
Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
Published on: October 7, 2014
Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans
Hae Yoon Choi1, Sungeun Kim, Ji Woo Park
1Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine (H.Y.C., H.C.H., H.J.Y., S.Y.B., K.M.C.), Korea University, Seoul 136-701, Korea; Department of Nuclear Medicine, College of Medicine (S.K.), Korea University, Seoul 136-701, Korea; AdipoGen, Inc (J.W.P., N.S.L., B.-S.Y.), Incheon 406-840, Korea; Department of Biostatistics, College of Medicine (S.W.H.), Korea University, Seoul 136-701, Korea; and Section of Endocrinology (J.Y.H., C.S.M.), VA Boston Healthcare System, Harvard Medical School, Boston, Massachusetts 02130.
Context:
Irisin is an exercise-induced novel myokine that drives brown-fat-like conversion of white adipose tissue and has been suggested to be a promising target for the treatment of obesity-related metabolic disorders.
Objective:
To assess the association of circulating irisin concentrations with brown adipose tissue (BAT) and/or sarcopenia in humans.
Setting And Design:
We examined irisin levels in 40 BAT-positive and 40 BAT-negative women detected by (18)F-fluorodeoxyglucose positron emission tomography ((18)FDG-PET). In a separate study, we also examined 401 subjects with or without sarcopenia defined by skeletal muscle mass index (SMMI) and appendicular skeletal muscle (ASM)/height(2) using dual-energy x-ray absorptiometry.
Results:
Among 6877 consecutive (18)FDG-PET scans in 4736 subjects, 146 subjects (3.1%) had positive BAT scans. The BAT-detectable group and the matched BAT-undetectable group did not differ in circulating irisin levels measured using two different ELISA kits (P = .747 and P = .160, respectively). Serum irisin levels were not different between individuals with sarcopenia and those without sarcopenia using either kit (P = .305 and P = .569, respectively). Also, serum irisin levels were not different between groups defined by ASM/height(2) using either kit (P = .352 and P = .134, respectively). Although visceral fat area and skeletal muscle mass showed significant difference according to tertiles of SMMI levels, irisin concentrations did not differ.
Conclusions:
Circulating irisin levels were not different in individuals with detectable BAT or those with sarcopenia compared with control subjects and were not correlated with SMMI.
More Related Videos
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
10:30Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT
Published on: April 1, 2019